Advertisement

Topics

Companies Related to "Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer" [Most Relevant Company Matches] - Page: 5 RSS

20:03 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Primary Operation SYnchronous meTastasized InVasivE Breast Cancer" Companies 101–125 of 4,200+

Relevant

Boston Breast Diagnostic Center

The Boston Breast Diagnostic Center was built from the ground up to provide women with comprehensive breast imaging care using state-of-the-art technology, all in a comfortable, spa-like environment. Services include digital mammography, high-resolution ultrasound, dedicated breast magnetic resonance imaging (MRI), as well as a full compliment of biopsy te...


iCAD Inc.

iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography and comp...

MetaStat, Inc.

MetaStat, Inc (OTCQB:MTST) is a molecular diagnostic company that develops and commercializes diagnostic tests for early and reliable prediction of systemic metastasis, the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body. MetaStat is focused on breast, prostate, lung and colorectal cancers, where syst...


RC Cancer Centers

Each year thousands of patients from around the world and across the United States turn to RC Cancer Centers seeking a cure for their prostate cancer and learn why they are The Choice for Saving Lives. Founded in 1979, Radiotherapy Centers of Georgia, a division of RC Cancer Centers, has earned a reputation for being one of the country's top cancer treatment and research facilities because of its ...

bioTheranostics, Inc.

bioTheranostics discovers, develops, and commercializes a growing array of molecular diagnostic tests for cancer patients. Leveraging its unique expertise in expression profiling and algorithm development, bioTheranostics is well positioned to be a partner and solution provider in metastatic cancer. The company operates a CLIA-certified, CAP-accredited dia...

IncellDx, Inc.

IncellDx, Inc. is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as HIV/AIDS, HPV/Cervical Cancer, Hepatitis, organ transplant infections, breast cancer and ovarian cancer.

National Breast Cancer Coalition Fund

The Breast Cancer Research Foundation (BCRF)

WHAT:

California Breast Cancer Research Program

iCAD, Inc.

iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography...

TechniScan, Inc.

Based in Salt Lake City, Utah, TechniScan, Inc. is a medical device company engaged in the development and commercialization of a non-invasive imaging tool designed to provide physicians with automated ultrasound images of the human breast. The system, known as SVARA ™, uses a process called Warm Bath Ultrasound (WBU™) to provide physicians with ...

Genzyme Genetics

Genzyme Genetics is a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counseling services. As a business unit of Genzyme Corporation, Genzyme Genetics employs over 1,500 people and has eight laboratories located across the United States and operations in Europe and Japan. Extensive Test MenuGenzyme Genetics leadership is evidenced by its state-of-the-...

Metropolitan Chicago Breast Cancer Task Force

Canadian Breast Cancer Foundation (Ontario Chapter)

Signet Laboratories Incorporated

Signet Laboratories, Inc is a medical biotechnology company focused in fields of cancer and infectious disease(Sepsis). Signet has developed proprietary antibody systems for the detection and management of breast and prostate cancer and Sepsis. Signet's patented technology will provide for determining risk in "normal patients who may be at increased risk for developing cancer at a time when proac...

WIN Consortium

The WIN Consortium (www.winconsortium.org) is a joint initiative of Institut Gustave Roussy (France) and University of Texas - MD Anderson Cancer Center (USA) which brings together 17 cancer centers around the world, the National Breast Cancer Foundation, Sage Bionetworks and three technology partners: Agilent Technologies, GE Healthcare and Life Technolog...

Austrian Breast & Colorectal Cancer Study Group (ABCSG)

Operation Walk Pittsburgh

Operation Walk Pittsburgh, an initiative of the AMD3 Foundation, is a non-profit, volunteer medical service program that provides free surgical treatment to patients with disabling arthritis in developing countries. Operation Walk also educates in-country orthopaedic surgeons, nurses, physical therapists and other health care professionals on the treatments, processes and surgical techniques for d...

Biomoda, Inc.

Biomoda (www.biomoda.com) is a cancer diagnostics company focused on the development of accurate, inexpensive and noninvasive tests for the early detection of cancer. In addition to its first product for lung cancer, diagnostic assays for cervical, breast, colorectal, bladder, and oral cancers are targeted for development. Current research and development ...

Provectus Pharmaceuticals

We are pleased you are visiting our Provectus Pharmaceuticals Web site. As you will see, our company is engaged in exciting research & development activities. This site is intended to provide a useful introduction into the innovative world of Provectus.We are a group of dedicated and entrepreneurial scientists, working together for the past 10 years, engaged in developing breakthrough technologies...

Breast Treatment Associates

Located in Fayetteville, Breast Treatment Associates is headed by Michael J. Cross, M.D., F.A.C.S., a Surgical Oncologist who specializes in the diagnosis and treatment of medical and surgical diseases of the breast. He is board-certified by the American Board of Surgery. Dr. Cross is a fellow of the American College of Surgeons and a member of the America...

Clarient, Inc

Clarient, Inc. is a comprehensive cancer services company and a growing leader in advanced cancer diagnostics. Our Automated Cellular Imaging System ( ACIS ®) has been used to manage more than 200,000 patients. ACIS ® is the only cellular imaging system with broad regulatory clearance and approved for the HER2, ER and PR markers for breast cancer. ACIS ® gives pathologists the confidence of qua...

Biomira

Biomira Inc. (TSE: BRA; Nasdaq: BIOM) is a product focused biotechnology company applying its proprietary immunotherapy and organic chemistry technologies for the development of cancer therapeutics. The Company's lead product, THERATOPE® vaccine, is currently being tested in a Phase III clinical trial for metastatic breast cancer. The Company's commitment to the development of products for the ...

Exact Sciences Corp.

Exact Sciences Corp. is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the ...

Orbix Medical

Orbix was founded by Professor Eyal Gur. It develops, manufactures and commercializes innovative solutions for breast plastic surgery. The company’s flagship OrbiShape system is part of a series of products that are set to significantly enhance and improve the outcome of the current breast procedures and aim to become the new gold standard of breast p...


More From BioPortfolio on "Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks